| 1 |
NCT03008798 |
Not yet recruiting |
Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117 |
- Occlusion and Stenosis of Unspecified Cerebral Artery
|
- Drug: Herbal Medicine C-117
- Drug: The Placebo of Herbal Medicine C-117
|
Interventional
|
Phase 2 |
- Guangzhou University of Traditional Chinese Medicine
- Liaocheng People's Hospital
- Liaoning thrombus treatment center of integrated chinese and western medicine
- (and 2 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Prevention
|
- the total number of all-cause mortality and all-cause stroke within 12 months
- The rate of intracranial in-stent restenosis
- The complications of intracranial in-stent restenosis
- (and 3 more...)
|
180 |
All |
18 Years to 80 Years (Adult, Older Adult) |
NCT03008798 |
2014A020221074 |
PRISIT |
January 2017 |
December 2019 |
December 2019 |
January 2, 2017 |
January 2, 2017 |
|
|
|
| 2 |
NCT03186079 |
Recruiting |
Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Constipation |
- Constipation
- Chinese Herbal Medicine
|
- Drug: Xiaojidaozhi Decoction oral capsules
- Drug: Placebo oral capsules
- Drug: Fiberform
- Behavioral: Toilet training
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Care Provider)
- Primary Purpose: Treatment
|
- Percentage of overall efficacy
- Baseline of constipation score in the beginning of treatment
- Change of constipation score from the baseline in the end of treatment
- (and 2 more...)
|
200 |
All |
4 Years to 14 Years (Child) |
NCT03186079 |
A333-2 |
|
May 1, 2017 |
February 2018 |
March 2018 |
June 14, 2017 |
July 17, 2017 |
|
- Shengjing Hospital
Shenyang, Liaoning, China
|
|
| 3 |
NCT03221894 |
Recruiting |
A Retrospective Study to Investigate the Additive Effectiveness of Chinese Herbal Medicine in Alzheimer's Disease |
|
- Dietary Supplement: GRAPE granules
|
Observational
|
|
- Dongzhimen Hospital, Beijing
- Beijing Hospital
- Chinese PLA General Hospital
- Peking University Third Hospital
|
Other |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- Mini-Mental State Examination (MMSE)
- Activities of Daily Living (ADLs)
- Clinical Dementia Rating (CDR)
- Neuropsychiatric Inventory (NPI)
|
90 |
All |
50 Years to 85 Years (Adult, Older Adult) |
NCT03221894 |
2017-IRT-0810 |
|
July 15, 2017 |
September 2017 |
September 2017 |
July 19, 2017 |
July 25, 2017 |
|
- Dongzhimen Hospital
Beijing, China
|
|
| 4 |
NCT03072225 |
Not yet recruiting |
Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine |
|
- Drug: Herbal Medicine C-117
- Drug: The Placebo of Herbal Medicine C-117
|
Interventional
|
Phase 2 |
- Guangzhou University of Traditional Chinese Medicine
- Guangzhou University of Traditional Chinese Medicine
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- The total number of all-cause mortality and all-cause stroke within 12 months
- The nature of Vulnerable plaque of carotid artery through color ultrasound
- The number of Vulnerable plaque of carotid artery through color ultrasound
- Blood lipid levels
|
120 |
All |
18 Years and older (Adult, Older Adult) |
NCT03072225 |
YN2014LN08 |
Spchim |
March 2017 |
December 2017 |
December 2018 |
March 7, 2017 |
March 7, 2017 |
|
|
|
| 5 |
NCT03132974 |
Not yet recruiting |
Evaluation of Efficacy and Safety of Herbal Medicine With Manipulation Therapy on Chronic Low Back Pain |
|
- Drug: Sogyeonghwalhyeol-tang granule
- Other: Sogyeonghwalhyeol-tang granule with manipulation procedure
- Other: Placebo with manipulation procedure
|
Interventional
|
Phase 2
Phase 3 |
- Gachon University Gil Oriental Medical Hospital
- Dunsan Korean Medicine Hospital of Daejeon University
- Semyung University Korean Medicine Hospital in Chungju
- Woosuk University Oriental Medical Center
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change from Baseline in Numeric Rating Scale of Pain
- Change from Baseline in 'Roland Morris Disability Questionnaire'
- Change from Baseline in European Quality of life 5 Dimension
|
150 |
All |
19 Years to 65 Years (Adult, Older Adult) |
NCT03132974 |
ISEE_2017_LBP |
|
September 1, 2017 |
December 31, 2018 |
December 31, 2019 |
April 28, 2017 |
August 2, 2017 |
|
|
|
| 6 |
NCT03577938 |
Not yet recruiting
New |
Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment |
- Acute on Chronic Liver Failure
- Traditional Chinese Medicine
- Hepatitis B
|
- Drug: Chinese herbal medicine
- Other: Control (blank)
|
Interventional
|
Not Applicable |
- Beijing 302 Hospital
- Beijing YouAn Hospital
- ShuGuang Hospital
- (and 15 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- transplant free survival
- liver function assessed by MELD score
- liver function assessed by Child-Pugh score
- (and 2 more...)
|
510 |
All |
16 Years to 65 Years (Child, Adult, Older Adult) |
NCT03577938 |
2018ZX10725506-002 |
|
September 1, 2018 |
December 30, 2020 |
December 30, 2020 |
July 4, 2018 |
July 4, 2018 |
|
- 302 military hospital of China
Beijing, Beijing, China - Beijing Ditan hospital
Beijing, Beijing, China - Beijing youan hospital
Beijing, Beijing, China - (and 12 more...)
|
|
| 7 |
NCT02988232 |
Recruiting |
Evaluation of Efficacy and Safety of Herbal Medicine on Work Related Chronic Low Back Pain |
|
- Drug: Sogyeonghwalhyeol-tang
- Drug: Placebo
|
Interventional
|
Phase 4 |
- Gachon University Gil Oriental Medical Hospital
- Sangji University Oriental Medical Center, Korea
- Semyung University Korean Medicine Hospital in Chungju, Korea
- Dunsan Korean Medicine Hospital of Daejeon University,Korea
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from Baseline in Numeric Rating Scale of Pain
- Change from Baseline in 'Roland Morris Disability Questionnaire'
- Change from Baseline in European Quality of life 5 Dimension
|
72 |
All |
19 Years to 65 Years (Adult, Older Adult) |
NCT02988232 |
ISEE_2015_WRMD |
WRMD |
July 2016 |
July 2018 |
December 2018 |
December 9, 2016 |
January 8, 2018 |
|
- Gachon University Gil Oriental Medical Hospital
Incheon, Korea, Republic of
|
|
| 8 |
NCT03479346 |
Not yet recruiting |
Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Factors |
- Obesity
- Metabolic Syndrome
|
|
Interventional
|
Not Applicable |
- Gachon University Gil Oriental Medical Hospital
- DongGuk University
- Wonkwang University Guangju Medical Center
- (and 2 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Changes from baseline in body weight
- Changes from baseline in body fat percentage
- Changes from baseline in fat mass
- (and 13 more...)
|
160 |
Female |
19 Years to 65 Years (Adult, Older Adult) |
NCT03479346 |
ISEE_2017_GGT |
|
April 28, 2018 |
April 1, 2020 |
December 1, 2020 |
March 27, 2018 |
March 27, 2018 |
|
|
|
| 9 |
NCT02651454 |
Recruiting |
A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial - |
- Metabolic Syndrome
- Obesity
|
- Drug: Daesiho-tang
- Drug: Jowiseungcheung-tang
- Drug: Placebo
|
Interventional
|
Phase 4 |
- Gachon University Gil Oriental Medical Hospital
- Sangji University Oriental Medical Hospital, Korea
- DongGuk University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Changes from baseline in body weight
- Changes from baseline in body fat percentage
- Changes from baseline in fat mass
- (and 9 more...)
|
120 |
Female |
18 Years to 65 Years (Adult, Older Adult) |
NCT02651454 |
ISEE_2015_OBESITY |
|
December 2015 |
December 2018 |
December 2019 |
January 11, 2016 |
January 8, 2018 |
|
- Gachon University Gil Oriental Medical Hospital
Incheon, Korea, Republic of
|
|
| 10 |
NCT03274544 |
Not yet recruiting |
Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF) |
- Idiopathic Pulmonary Fibrosis
|
|
Interventional
|
Not Applicable |
- The University of Hong Kong
- Queen Mary Hospital, Hong Kong
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Annual rate of change in forced expiratory vital capacity (FVC)
- Changes in SGRQ score
- Changes in SF-36 score
- (and 2 more...)
|
30 |
All |
40 Years to 75 Years (Adult, Older Adult) |
NCT03274544 |
UW 17-283 |
|
May 14, 2018 |
August 31, 2019 |
August 31, 2020 |
September 7, 2017 |
May 7, 2018 |
|
- Queen Mary Hospital
Hong Kong, Hong Kong
|
|
| 11 |
NCT02879006 |
Recruiting |
E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy |
|
- Drug: Chinese Herbal Medication
- Drug: Placebo
- Drug: Omalizumab
- Drug: Multi OIT
|
Interventional
|
Phase 2 |
- Xiu-Min Li
- Icahn School of Medicine at Mount Sinai
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Sustained unresponsiveness
- Desensitizing to 4444mg
- High level of desensitization to 7444mg or higher
|
34 |
All |
6 Years to 40 Years (Child, Adult) |
NCT02879006 |
GCO 16-1384 |
|
August 2016 |
December 2021 |
December 2021 |
August 25, 2016 |
January 23, 2018 |
|
- Johns Hopkins University
Baltimore, Maryland, United States - Icahn School of Medicine at Mount Sinai
New York, New York, United States
|
|
| 12 |
NCT02795390 |
Recruiting |
Clinical Trial on Palliative Cancer Patients With Constipation |
|
- Drug: Chinese herbal medicine
- Drug: Placebo
|
Interventional
|
Phase 2 |
- Hong Kong Baptist University
- Caritas Medical Centre
- Yan Chai Hospital
- (and 3 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Global symptom improvement (improved / same / worse)
- Number of bowel movement (times/day)
- Stool form
- (and 8 more...)
|
60 |
All |
18 Years and older (Adult, Older Adult) |
NCT02795390 |
HKBU/KWC/PC2014 |
|
November 2016 |
November 2018 |
November 2018 |
June 10, 2016 |
August 9, 2017 |
|
- Caritas Medical Centre
Hong Kong, Hong Kong - Hong Kong Buddhist Hospital
Hong Kong, Hong Kong - Our Lady of Maryknoll Hospital
Hong Kong, Hong Kong
|
|
| 13 |
NCT02975011 |
Recruiting |
Effectiveness and Safety of Korean Medicine for Lumbar Stenosis Patients With Sciatica |
|
- Drug: Herbal medicine
- Procedure: Chuna manipulation
- Procedure: Bee venom pharmacopuncture
- (and 5 more...)
|
Observational
|
|
- Jaseng Medical Foundation
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- Change in Numeric rating scale (NRS) of low back pain
- Change in Numeric rating scale (NRS) of radiating leg pain
- Numeric rating scale (NRS) of low back pain
- (and 7 more...)
|
120 |
All |
19 Years to 75 Years (Adult, Older Adult) |
NCT02975011 |
JS-CT-2016-03 |
|
March 4, 2017 |
September 2018 |
September 2018 |
November 29, 2016 |
April 5, 2018 |
|
- Jaseng Medical Foundation
Seoul, Korea, Republic of
|
|
| 14 |
NCT03450902 |
Recruiting |
Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence |
|
- Combination Product: Chinese herb & acupuncture
- Combination Product: Chinese herb & sham acupuncture
- Combination Product: Placebo & acupuncture
- Other: Placebo & sham acupuncture
|
Interventional
|
Phase 2 |
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
|
Other |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in incontinence episode per 24 h
- Change in ICIQ-SF questionnaire
- Change in I-QOL questionnaire
- proportion of participants with more than 50% improvement in incontinence episodes per 24h
|
120 |
Female |
18 Years to 65 Years (Adult, Older Adult) |
NCT03450902 |
Z161100000516156 |
|
March 14, 2018 |
August 2019 |
August 2019 |
March 1, 2018 |
March 29, 2018 |
|
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, Beijing, China
|
|
| 15 |
NCT03310385 |
Not yet recruiting |
Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis |
|
|
Interventional
|
Phase 2 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in BSS(Bronchitis Severity Score)
- Change in Questionnaire of Clinical Symptoms of Cough and Sputum
- Change in Leicester Cough Questionnaire-acute(LCQ-acute)
- (and 3 more...)
|
150 |
All |
19 Years to 75 Years (Adult, Older Adult) |
NCT03310385 |
DJRM-2017-01 |
|
January 2018 |
December 2018 |
December 2018 |
October 16, 2017 |
October 17, 2017 |
|
- Dunsan Korean Medicine Hospital, Daejeon University
Daejeon, Korea, Republic of
|
|
| 16 |
NCT03571503 |
Not yet recruiting
New |
The Effectiveness of Doin (Conduction Exercise) of the Pelvic Joint for HLD With Radiating Leg Pain |
- Intervertebral Disc Displacement
- Sciatica
- Sciatic Radiculopathy
|
- Procedure: Doin (conduction exercise)
- Drug: Herbal medicine
- Procedure: Chuna manual therapy
- (and 6 more...)
|
Observational
|
|
- Jaseng Medical Foundation
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- Change in Numeric Rating Scale (NRS) of low back pain
- Change in Numeric Rating Scale (NRS) of radiating leg pain
- Change in Oswestry Disability Index (ODI)
- (and 18 more...)
|
40 |
All |
19 Years to 70 Years (Adult, Older Adult) |
NCT03571503 |
JS-CT-2018-02 |
|
June 2018 |
December 2018 |
March 2019 |
June 27, 2018 |
June 27, 2018 |
|
|
|
| 17 |
NCT03365336 |
Recruiting |
Influenza Management With Polyherbal Formulation |
|
- Drug: polyherbal formulation
- Drug: Oseltamivir 75mg
|
Interventional
|
Not Applicable |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Time to improvement of symptoms
- Percentage change in participants positive for influenza virus titer and viral RNA at end of treatment
- Time to alleviation of symptoms
- (and 6 more...)
|
100 |
All |
18 Years and older (Adult, Older Adult) |
NCT03365336 |
OI-008-2017 |
|
February 1, 2018 |
May 15, 2018 |
May 15, 2018 |
December 7, 2017 |
April 11, 2018 |
|
- Mazumdar Shaw Medical Centre
Bangalore, Karnataka, India
|
|
| 18 |
NCT03354026 |
Not yet recruiting |
Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy |
- Intracerebral Hemorrhage, Hypertensive
- Traditional Chinese Medicine
|
- Drug: AICH-PXZY
- Drug: AICH-without PXZY
- Drug: AICH-placebo
|
Interventional
|
Phase 4 |
- Guangzhou University of Traditional Chinese Medicine
- Lianjiang people's Hospital
- Shenyang Second Hospital of traditional Chinese Medicine
- (and 5 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Hematoma enlargement
- GCS scoring scale
- National Institute of Health of stroke scale
- (and 4 more...)
|
306 |
All |
18 Years to 80 Years (Adult, Older Adult) |
NCT03354026 |
JDZX2015048 |
CERBSTTSCH |
November 2017 |
December 2022 |
December 2022 |
November 27, 2017 |
November 27, 2017 |
|
- Guangdong Provincial Science and Technology Agency
Guangzhou, Guangdong, China - Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, China
|
|
| 19 |
NCT03219515 |
Not yet recruiting |
Herbal Medication (Gongjin-dan) for Chronic Dizziness |
|
- Drug: Gongjin-Dan
- Drug: Placebo
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Dizziness Handicap Inventory (DHI), change between baseline and endpoint
- Dizziness Handicap Inventory (DHI), change between baseline and day 14, day 28, day 42
- Mean Vertigo Score (MVS), changes between baseline and day 28 and day 56
- (and 10 more...)
|
78 |
All |
20 Years to 79 Years (Adult, Older Adult) |
NCT03219515 |
HB16C0010-GJD |
GOODNESS |
April 1, 2018 |
August 30, 2020 |
August 30, 2020 |
July 17, 2017 |
September 25, 2017 |
|
- Semyung University Korean Medicine Hospital
Chungju, Chungcheongbuk-do, Korea, Republic of - Dongguk University Ilsan Oriental Hospital
Goyang, Gyeonggi-do, Korea, Republic of - Pusan National University Korean Medicine Hospital
Yangsan, Gyeongsangnam-do, Korea, Republic of - Kyung Hee University Korean Medicine Hospital
Seoul, Special Seoul City, Korea, Republic of
|
|
| 20 |
NCT02982603 |
Recruiting |
Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment |
- Mild Cognitive Impairment
- Herbal Medicine Allergy
|
- Drug: Qinggongshoutao Bolus
- Drug: Ginkgo Biloba Extract 761
- Drug: Placebos
|
Interventional
|
Phase 4 |
- Dongzhimen Hospital, Beijing
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from baseline to end of double-blind treatment of Alzheimer Disease Assessment Scale-cognitive subscale
- Change from baseline to end of double-blind treatment of rate of conversion to dementia
- Mini-Mental State Examination(MMSE)
- (and 2 more...)
|
360 |
All |
55 Years to 85 Years (Adult, Older Adult) |
NCT02982603 |
Z12020286 |
|
January 2015 |
December 2017 |
|
December 5, 2016 |
December 7, 2016 |
|
- Dongzhimen Hospital ,Beijing University of Chinese Medicine
Beiing, Beijing, China
|
|
| 21 |
NCT02737735 |
Recruiting |
The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation |
- Carcinoma, Non-Small-Cell Lung
|
- Drug: standard chemotherapy medicine combined with Chinese herbs
- Drug: standard chemotherapy medicine
|
Interventional
|
Phase 1 |
- First Affiliated Hospital, Sun Yat-Sen University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Overall survival rate
- progression-free survival rate
|
200 |
All |
18 Years and older (Adult, Older Adult) |
NCT02737735 |
SBao-guo |
|
March 2016 |
December 2019 |
January 2020 |
April 14, 2016 |
April 14, 2016 |
|
- The First Affiliated Hospital of Sun-yat Sen University
GuangZhou, Guangdong, China
|
|
| 22 |
NCT02923622 |
Not yet recruiting |
Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer |
- Advanced Colorectal Cancer
- Traditional Chinese Medicine
|
- Other: Traditional Chinese medicine herbals
- Other: Integrated traditional Chinese and Western medicine
- Other: Western medicine
|
Observational
|
|
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Beijing Municipal Science & Technology Commission
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Overall survival
- Progress free survival
- Quality of life as assessed by FACT-C v4.0
- (and 3 more...)
|
384 |
All |
18 Years to 80 Years (Adult, Older Adult) |
NCT02923622 |
D161100005116002 |
|
September 2016 |
March 2020 |
|
October 4, 2016 |
October 4, 2016 |
|
- Oncology Department of Xiyuan hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing, China
|
|
| 23 |
NCT03025399 |
Not yet recruiting |
Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy |
- Diabetic Non-proliferative Retinopathy
- Type2 Diabetes
|
- Drug: Tangwang prescription
- Drug: Placebo
|
Interventional
|
Early Phase 1 |
- Fengmei Lian
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
- (and 7 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- the changes of degree of retinal microvascular lesions before and after treatment (no, mild non proliferative phase, moderate non proliferative phase, severe non proliferative phase, proliferative phase)
- Change of the number of micro hemangioma of diabetic retinopathy
- Change of the number of microvascular bleeding of diabetic retinopathy
- (and 3 more...)
|
384 |
All |
30 Years to 70 Years (Adult, Older Adult) |
NCT03025399 |
2015Tangwang Prescription |
|
February 2017 |
May 2019 |
May 2020 |
January 19, 2017 |
January 20, 2017 |
|
|
|
| 24 |
NCT03009864 |
Not yet recruiting |
The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage |
|
- Drug: Tangshen Prescription
- Drug: Placebos
|
Interventional
|
Early Phase 1 |
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Anhui Provincial Hospital of Traditional Chinese Medicine
- Zhengzhou City Hospital of Traditional Chinese Medicine
- (and 11 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- changes of albumin-to-creatinine ration
- number of participants of diabetic kidney disease in macroalbuminuria stage
- number of participants whose microalbuminuria excretion rate < 20ug/min
- (and 2 more...)
|
632 |
All |
30 Years to 70 Years (Adult, Older Adult) |
NCT03009864 |
201507001-11Tangshen |
|
January 2017 |
September 2019 |
May 2020 |
January 4, 2017 |
January 4, 2017 |
|
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing, China
|
|
| 25 |
NCT03506919 |
Recruiting |
Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis |
|
|
Interventional
|
Phase 1
Phase 2 |
- Shifa Ul Mulk Memorial Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Reduction in Serum Uric Acid level
|
200 |
All |
15 Years to 60 Years (Child, Adult) |
NCT03506919 |
003 |
|
January 1, 2018 |
April 30, 2018 |
June 30, 2018 |
April 24, 2018 |
April 24, 2018 |
|
- clinical trial was conducted in Bahawalpur, and Rawalpindi
Bahawalpur, Punjab, Pakistan
|
|
| 26 |
NCT02855658 |
Recruiting |
Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome |
|
|
Interventional
|
Phase 2 |
- China Medical University Hospital
- Chang Gung Memorial Hospital
- China Medical University, China
- National Research Program for Biopharmaceuticals, Taiwan
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Ocular surface disease index (OSDI)
- EULAR Sjogren's syndrome patient reported index (ESSPRI)
- Sjogren's syndrome symptoms Questionnaire
- (and 6 more...)
|
90 |
All |
20 Years to 75 Years (Adult, Older Adult) |
NCT02855658 |
CMUH105-REC3-025 |
|
February 2014 |
October 2016 |
April 2017 |
August 4, 2016 |
August 4, 2016 |
|
- Taoyuan Chang Gung Memorial Hospital
Gueishan Township, Taiwan - China Medical University Hospital
Taichung, Taiwan
|
|
| 27 |
NCT03447925 |
Recruiting |
Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients |
|
- Drug: Medicinal Plant
- Drug: Salicylate
- Drug: Vaseline
|
Interventional
|
Phase 2 |
- Universidade do Vale do Sapucai
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Measures of the sites with plantar keratosis
|
90 |
All |
18 Years and older (Adult, Older Adult) |
NCT03447925 |
65431417.4.0000.5102 |
|
June 1, 2017 |
October 1, 2018 |
January 1, 2019 |
February 27, 2018 |
February 28, 2018 |
|
- Beatriz B Martinez
Pouso Alegre, Minas Gerais, Brazil
|
|
| 28 |
NCT03054974 |
Recruiting |
TCM Clinical Practice Rehabilitation of Post-stroke Spasticity |
|
- Other: Modern rehabilitation treatment
- Other: Modern rehabilitation &TCM
- Other: modern rehabilitation &Baimai Ruangao
- Other: modern rehabilitation &Tibetan medicine
|
Interventional
|
Not Applicable |
- The First Affiliated Hospital with Nanjing Medical University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Modified Ashworth Scale
- Fugl-Meyer Moter Assessment
|
1208 |
All |
18 Years to 85 Years (Adult, Older Adult) |
NCT03054974 |
2013BAI10B04 |
|
January 2013 |
December 2017 |
December 2018 |
February 16, 2017 |
February 16, 2017 |
|
- Jiangsu Province Hospital
Nanjing, Jiangsu, China
|
|
| 29 |
NCT03403569 |
Not yet recruiting |
Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection |
|
- Drug: Triptolide Wilfordii
- Drug: Placebo Oral Tablet
|
Interventional
|
Phase 3 |
- Peking Union Medical College Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- CD4 T cell counts and HIV RNA
- Immune activation
- Inflammation level
- HIV reservoir
|
300 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT03403569 |
PekingUMCH record JS-985 |
|
March 1, 2018 |
December 31, 2019 |
December 31, 2019 |
January 18, 2018 |
January 18, 2018 |
|
|
|
| 30 |
NCT00442091 |
Recruiting |
Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema |
- Vesicular Palmoplantar Eczema
- Pompholyx
|
|
Interventional
|
Not Applicable |
- Odense University Hospital
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Improvement in dyshidrotic hand eczema in the study period assessed by HECSI score.
- Improvement in dyshidrotic eczema in the study period assessed by the patient (Visual Analog Scale).
|
4 |
All |
18 Years and older (Adult, Older Adult) |
NCT00442091 |
20070010 |
|
December 2010 |
December 2019 |
December 2019 |
March 1, 2007 |
September 20, 2017 |
|
- Department of Dermatology, Odense University Hospital
Odense, Denmark
|
|
| 31 |
NCT03171597 |
Not yet recruiting |
Research on the Clinical Effect of Effective Prescription in Treating Unstable Angina. |
|
- Drug: Anti-Platelet Drugs
- Drug: Lipid Regulating Drugs
- Drug: Coronary Vasodilator
- (and 3 more...)
|
Interventional
|
Phase 4 |
- Jun Li
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Mortality
- Myocardial enzymes
- Blood lipid
- (and 2 more...)
|
240 |
All |
35 Years to 70 Years (Adult, Older Adult) |
NCT03171597 |
YXFJ-2017 |
|
August 2017 |
October 2019 |
December 2019 |
May 31, 2017 |
May 31, 2017 |
|
|
|
| 32 |
NCT03532789 |
Not yet recruiting |
Herbal Patch for Overactive Bladder |
- Overactive Bladder Syndrome
|
- Drug: herbal patch
- Drug: placebo patch
|
Interventional
|
Phase 2
Phase 3 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
|
62 |
All |
20 Years and older (Adult, Older Adult) |
NCT03532789 |
ECKIRB1051203 |
|
May 14, 2018 |
October 31, 2019 |
December 31, 2019 |
May 22, 2018 |
May 22, 2018 |
|
|
|
| 33 |
NCT03081819 |
Recruiting |
A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer |
|
|
Interventional
|
Phase 1 |
- Kyunghee University Medical Center
|
Other |
- Intervention Model: Sequential Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
|
18 |
All |
19 Years and older (Adult, Older Adult) |
NCT03081819 |
ISEE_2015_SH003 |
|
March 30, 2017 |
December 2018 |
February 2019 |
March 16, 2017 |
February 28, 2018 |
|
- Ajou University Hospital
Suwon, Korea, Republic of
|
|
| 34 |
NCT03135821 |
Recruiting |
Traditional Chinese Medicine for Treatment of Irritable Bowel Syndrome |
|
|
Interventional
|
Phase 2
Phase 3 |
- Singapore General Hospital
- Singapore College of Traditional Chinese Medicine
- Duke-NUS Graduate Medical School
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change from baseline in IBS-Symptom Severity Score at 8 weeks
|
104 |
All |
21 Years to 80 Years (Adult, Older Adult) |
NCT03135821 |
SGH-TCM-GASTR-TCMIBS |
|
March 2015 |
November 2017 |
November 2017 |
May 1, 2017 |
May 1, 2017 |
|
- Singapore General Hospital
Singapore, Singapore
|
|
| 35 |
NCT02858856 |
Recruiting |
Clinical Trial of Sipjeondaebo-tang on Fatigue of Breast Cancer Patients |
|
|
Interventional
|
Not Applicable |
- Kyunghee University Medical Center
- Catholic Kwandong University
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Brief Fatigue Inventory change
- EORTC-QLQ-C30 change
- EORTC-QLQ-BR23 change
|
48 |
All |
18 Years and older (Adult, Older Adult) |
NCT02858856 |
ISEE_2016_SJDBT |
|
March 20, 2017 |
March 2018 |
June 2018 |
August 8, 2016 |
September 15, 2017 |
|
- International St. Mary's Hospital
Incheon, Korea, Republic of
|
|
| 36 |
NCT03552263 |
Not yet recruiting |
Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) |
- Acute Mountain Sickness (AMS)
|
- Drug: T89 capsule
- Drug: Placebo capsule
|
Interventional
|
Phase 2 |
- Tasly Pharmaceuticals, Inc.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- The LLSS self- and clinical assessments score on Day 16 morning(next morning of arrival at high altitude) between T89 and Placebo groups.
- The area under the curve (AUC) of LLSS self- and clinical assessments score in the mean LLSS score-time profile during rapid ascent (Days 15-19) between T89 and Placebo groups.
- The total incidence of AMS evaluated by LLSS between T89 and Placebo groups.
- (and 9 more...)
|
120 |
All |
18 Years to 55 Years (Adult) |
NCT03552263 |
T89-30-AMS |
|
June 1, 2018 |
September 20, 2018 |
February 28, 2019 |
June 11, 2018 |
June 11, 2018 |
|
- Barcroft Lab, White Mountain Research Center, Barcroft Station
Bishop, California, United States - Hypoxia Research Lab, UCSF Parnassus Campus, S-256
San Francisco, California, United States
|
|
| 37 |
NCT02725697 |
Recruiting |
Treatment of Complaints Following Sports Injuries With Traditional Chinese Medicine |
|
|
Observational
|
|
- Sabine Klein
- Swiss Professional Organization for Traditional Chinese Medicine
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- change in minimal and maximal pain
- change in limitation during sports
- medication intake
- (and 3 more...)
|
60 |
All |
18 Years and older (Adult, Older Adult) |
NCT02725697 |
SBO-TCM 001 |
|
April 2016 |
December 2018 |
June 2019 |
April 1, 2016 |
May 2, 2017 |
|
- Poliklinik für Chinesische Medizin
Horgen, ZH, Switzerland - Praxis für TCM
Zürich, ZH, Switzerland - proSANUS
Zürich, ZH, Switzerland
|
|
| 38 |
NCT02380794 |
Recruiting |
Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule |
- Peripheral Arterial Disease
- Intermittent Claudication
|
- Drug: Danshen Gegen Capsule
- Drug: Placebo
|
Interventional
|
Phase 2 |
- Chinese University of Hong Kong
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Change in total distance walked on a standardized graded treadmill
- Change in distance walked to onset of claudication
- Change in health related quality of life assessed by EuroQol-5 Dimension
- (and 4 more...)
|
102 |
All |
40 Years and older (Adult, Older Adult) |
NCT02380794 |
DG-PAD |
|
October 28, 2015 |
June 2, 2017 |
December 31, 2017 |
March 5, 2015 |
July 21, 2017 |
|
- Prince of Wales Hospital
Shatin, New Territories, Hong Kong
|
|
| 39 |
NCT02840890 |
Recruiting |
Osteopathy and Prevention of Gastrointestinal Side Effects in Women Treated for Breast Cancer |
|
- Procedure: osteopathic technique
- Procedure: Placebo
|
Interventional
|
Not Applicable |
- Centre Georges Francois Leclerc
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- episode of nausea and / or vomiting
- episode of constipation
- Quality of life questionnaire(QLQ-C30)
|
94 |
Female |
18 Years to 99 Years (Adult, Older Adult) |
NCT02840890 |
PREDIGOSTEO |
PREDIGOSTEO |
November 2015 |
November 2018 |
June 2019 |
July 21, 2016 |
January 25, 2018 |
|
|
|
| 40 |
NCT03091634 |
Recruiting |
The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome. |
- Qi Stagnation and Blood Stasis Syndrome
|
- Drug: xue-fu-zhu-yu capsule
- Drug: xue-fu-zhu-yu capsule simulated agent
|
Interventional
|
Phase 2 |
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- China Food and Drug Administration
- Chinese Academy of Medical Sciences
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- The Traditional Chinese Medicine PRO Scale
- The single symptom and sign scale of QS&BSS
- The pain scale of QS&BSS
|
120 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT03091634 |
HHe |
TROTEASOTXZC |
May 6, 2017 |
November 1, 2018 |
December 1, 2018 |
March 27, 2017 |
July 26, 2017 |
|
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, China - Huguosi TCM Hospital Affiliated to Beijing University of CM
Beijing, China - Wangjing Hospital, China Academy of Chinese Medical Sciences
Beijing, China
|
|
| 41 |
NCT03382145 |
Recruiting |
A Review on the Outcome of Patient Managed in Postmenopausal Bleeding Clinic |
|
|
Observational
|
|
- Chinese University of Hong Kong
|
Other |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- To assess any correlation between histolopathology and transvaginal ultrasonography in postmenopausal women at Tertiary centre
|
12000 |
Female |
Child, Adult, Older Adult |
NCT03382145 |
CRE 2017.475 |
|
February 1, 2018 |
December 31, 2019 |
December 31, 2019 |
December 22, 2017 |
February 5, 2018 |
|
- The Chinese University of Hong Kong
Hong Kong, Hong Kong
|
|
| 42 |
NCT03230071 |
Not yet recruiting |
Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia |
|
- Drug: TMBCZG
- Other: placebo
|
Interventional
|
Phase 2 |
- Dongzhimen Hospital, Beijing
- Beijing Union pharmaceutical factory II
- Beijing Compete Medical Technology Development Co. Ltd.
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Vascular Dementia Assessment Scale-cognitive subscale(VADAS-Cog)
- Clinical Dementia Rating-Sum of Boxes (CDR-SB)
- Mini-Mental State Examination (MMSE)
- Activities of daily living (ADL)
|
160 |
All |
55 Years to 80 Years (Adult, Older Adult) |
NCT03230071 |
P2017-03-BDY-03-V03 |
|
August 1, 2017 |
December 30, 2019 |
June 30, 2020 |
July 26, 2017 |
July 28, 2017 |
|
- Dongzhimen Hospital ,Beijing University of Chinese Medicine
Beijing, Beijing, China
|
|
| 43 |
NCT03192748 |
Not yet recruiting |
A Registry Study of Runzaozhiyang Capsule Used in Clinical Real World |
|
|
Observational
|
|
- China Academy of Chinese Medical Sciences
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- China Academy of Chinese Medical Sciences
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Is there any abnormality in liver function test index（ALT、AST、TBil、GGT） after using runzaozhiyang capsule around two weeks later?
- Is there any abnormality in renal function test index（Bun、Cr） after medication?
- Is there any abnormality in ECG after medication?
- Is there any abnormality in basic life sign（body temperature, blood pressure and pulse）？
|
3000 |
All |
Child, Adult, Older Adult |
NCT03192748 |
Runzao |
|
June 19, 2017 |
June 19, 2017 |
June 30, 2019 |
June 20, 2017 |
June 20, 2017 |
|
|
|
| 44 |
NCT03197844 |
Not yet recruiting |
Study on Registration of Xinyuan Capsule |
|
|
Observational
|
|
- China Academy of Chinese Medical Sciences
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- China Academy of Chinese Medical Sciences
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Is there any abnormality in liver function test index（ALT、AST、TBil、GGT）after using xinyuan capsule around four weeks later?
- Is there any abnormality in renal function test index（Bun、Cr） after using xinyuan capsule around four weeks later?
- Is there any abnormality in ECG after using xinyuan capsule around four weeks later?
- Is there any abnormality in basic life sign（body temperature, blood pressure and pulse）during using xinyuan capsule around four weeks？
|
3000 |
All |
Child, Adult, Older Adult |
NCT03197844 |
xinyuan |
|
June 23, 2017 |
June 23, 2017 |
December 31, 2018 |
June 23, 2017 |
June 23, 2017 |
|
|
|
| 45 |
NCT03384667 |
Recruiting |
Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer |
- Postoperative Cough
- Lung Cancer
|
- Drug: Maekmoondong-tang
- Drug: Placebo
|
Interventional
|
Phase 2
Phase 3 |
- Seong-Gyu Ko
- Kyunghee University Medical Center
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Leicester Cough Questionnaire (LCQ)
- Cough VAS
- Yin deficiency scale
|
96 |
All |
20 Years and older (Adult, Older Adult) |
NCT03384667 |
ISEE_MMDT_2017 |
|
February 22, 2018 |
December 31, 2018 |
March 31, 2019 |
December 27, 2017 |
February 28, 2018 |
|
- Korea University Guro Hospital
Seoul, Korea, Republic of
|
|
| 46 |
NCT03033290 |
Recruiting |
Traditional Chinese Medicine on Gut Microbiota and Allergic Diseases |
|
- Drug: Bu-Zhong-Yi-Qi-Tang
- Drug: placebo
|
Interventional
|
Phase 3 |
- Chang Gung Memorial Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Changes in allergic rhinitis symptom severity
- Improvement of fatigue
- Improvement of life quality
- (and 6 more...)
|
60 |
All |
20 Years to 60 Years (Adult) |
NCT03033290 |
CORPG1F0011 |
|
January 10, 2018 |
July 31, 2020 |
July 31, 2020 |
January 26, 2017 |
January 26, 2018 |
|
- Chang Gung Memorial Hospital
Taoyuan, Taiwan
|
|
| 47 |
NCT03192787 |
Not yet recruiting |
A Registry Study of Sanwujiaowan Capsule Used in Clinical Real World |
|
|
Observational
|
|
- Yanming Xie
- Xiangya Hospital of Central South University
- China Academy of Chinese Medical Sciences
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Is there any abnormality in liver function test index（ALT、AST、TBil、GGT） after using sanwujiaowan capsule around four weeks later?
- Is there any abnormality in renal function test index（Bun、Cr） after using sanwujiaowan capsule around four weeks later?
- Is there any abnormality in ECG after using sanwujiaowan capsule around four weeks later?
- Is there any abnormality in basic life sign（body temperature, blood pressure and pulse）during using sanwujiaowan capsule around four weeks？
|
3000 |
All |
Child, Adult, Older Adult |
NCT03192787 |
Sanwujiaowan |
|
June 19, 2017 |
June 19, 2017 |
December 31, 2018 |
June 20, 2017 |
June 20, 2017 |
|
|
|
| 48 |
NCT03010241 |
Not yet recruiting |
The Multi-Centric Clinical Study of Chinese Medicine Intervention on Diabetes Distal Symmetric Polyneuropathy. |
|
- Drug: Tangbi (prescription)
- Drug: Placebo
|
Interventional
|
Early Phase 1 |
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
- Zhengzhou City Hospital of Traditional Chinese Medicine
- (and 4 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- The clinical symptoms and signs of patients were recorded by Michigan Diabetic Neuropathy Score(MDNS), and the changes of Michigan Diabetic Neuropathy Score(MDNS) were compared between the two groups before and after medication
- nerve conduction velocity changes The changes in nerve conduction velocity of each nerve were compared before and after taking medicine.
- Clinical symptoms and signs change The clinical symptoms and signs of the patients were compared before and after taking the medicine.
|
188 |
All |
30 Years to 70 Years (Adult, Older Adult) |
NCT03010241 |
2016Tangbi Prescription |
|
January 2017 |
November 2019 |
May 2020 |
January 5, 2017 |
January 5, 2017 |
|
|
|
| 49 |
NCT02616120 |
Recruiting |
Effect of SQJZ Herbal Mixtures on Non-motor Symptoms of Parkinson's Disease |
|
- Drug: SQJZ herbal mixtures
- Drug: Placebo
|
Interventional
|
Phase 2 |
- Dongzhimen Hospital, Beijing
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- changes of The Nonmotor Symptoms Scale (NMSS) from baseline after 12-weeks treatment.
- changes of The Unified Parkinson's Disease Rating Scale (UPDRS) from baseline after 12-weeks treatment.
- changes of The Parkinson's Disease Questionnaire-39 (PDQ-39) from baseline after 12-weeks treatment.
|
240 |
All |
18 Years to 80 Years (Adult, Older Adult) |
NCT02616120 |
ECPJ-BDY-2014-27
SHOUFA 2014-1-4 |
ESNMS |
May 2015 |
June 2018 |
December 2018 |
November 26, 2015 |
October 18, 2017 |
|
- Dongzhimen hospital, Beijing University of Chinese Medicine
Beijing, Beijing, China
|
|
| 50 |
NCT02982642 |
Not yet recruiting |
Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment |
- Mild Cognitive Impairment
|
- Drug: 1612 capsule
- Drug: Placebos
|
Interventional
|
Phase 4 |
- Dongzhimen Hospital, Beijing
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in cognitive scores: Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog)
- Change from baseline to end of double-blind treatment of rate of dementia conversion from mild cognitive impairment
- Change from baseline to end of double-blind treatment of Mini-Mental State Examination(MMSE)
- (and 2 more...)
|
240 |
All |
55 Years to 85 Years (Adult, Older Adult) |
NCT02982642 |
Z20055424 |
|
January 2017 |
December 2018 |
|
December 5, 2016 |
December 7, 2016 |
|
- Dongzhimen Hospital ,Beijing University of Chinese Medicine
Beiing, Beijing, China
|
|
Create an RSS feed from your search for:
Download the search results for: